These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effect of terbinafine on theophylline pharmacokinetics in healthy volunteers. Trépanier EF; Nafziger AN; Amsden GW Antimicrob Agents Chemother; 1998 Mar; 42(3):695-7. PubMed ID: 9517954 [TBL] [Abstract][Full Text] [Related]
6. Influenza vaccine may enhance theophylline toxicity. A case report and review of the literature. Hamdy RC; Micklewright M; Beecham VF; Moore SW J Tenn Med Assoc; 1995 Dec; 88(12):463-4. PubMed ID: 8531477 [No Abstract] [Full Text] [Related]
8. Dose response relation to oral theophylline in severe chronic obstructive airways disease. Chrystyn H; Mulley BA; Peake MD BMJ; 1988 Dec; 297(6662):1506-10. PubMed ID: 3147048 [TBL] [Abstract][Full Text] [Related]
9. Theophylline: taking it to a new level. Messerschmidt K S D J Med; 1996 Jun; 49(6):201-2. PubMed ID: 8693341 [No Abstract] [Full Text] [Related]
10. Effects of theophylline withdrawal in severe chronic obstructive pulmonary disease. Kirsten DK; Wegner RE; Jörres RA; Magnussen H Chest; 1993 Oct; 104(4):1101-7. PubMed ID: 8404175 [TBL] [Abstract][Full Text] [Related]
11. Use of theophylline in the treatment of COPD. Ramsdell J Chest; 1995 May; 107(5 Suppl):206S-209S. PubMed ID: 7743828 [No Abstract] [Full Text] [Related]
12. Guide to therapy with theophylline for the treatment of obstructive lung disease. Bernocchi D; Castiglioni CL J Int Med Res; 1988; 16(1):1-18. PubMed ID: 3280361 [TBL] [Abstract][Full Text] [Related]